2018-2023 Global Fragment-based Drug Discovery Market Report (Status and Outlook)

October 2018 | 135 pages | ID: 2E189150B12EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Fragment-based Drug Discovery market for 2018-2023.
The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices.

Over the next five years, LPI(LP Information) projects that Fragment-based Drug Discovery will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Fragment-based Drug Discovery market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Fragment Screening
• Fragment Optimization

Segmentation by application:

• Biopharmaceutical Companies
• CROs
• Academic and Research Institutions

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Astex Pharmaceuticals
• Alveus Pharmaceuticals
• Beactica
• Charles River Laboratories
• Crown Bioscience
• Emerald BioStructures
• Evotec
• Kinetic Discovery
• Proteros Fragments
• Sprint Bioscience
• Structure Based Design
• Sygnature Discovery

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global Fragment-based Drug Discovery market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Fragment-based Drug Discovery market by identifying its various subsegments.
• Focuses on the key global Fragment-based Drug Discovery players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Fragment-based Drug Discovery with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Fragment-based Drug Discovery submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2018-2023 GLOBAL FRAGMENT-BASED DRUG DISCOVERY MARKET REPORT (STATUS AND OUTLOOK)

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Fragment-based Drug Discovery Market Size 2013-2023
  2.1.2 Fragment-based Drug Discovery Market Size CAGR by Region
2.2 Fragment-based Drug Discovery Segment by Type
  2.2.1 Fragment Screening
  2.2.2 Fragment Optimization
2.3 Fragment-based Drug Discovery Market Size by Type
  2.3.1 Global Fragment-based Drug Discovery Market Size Market Share by Type (2013-2018)
  2.3.2 Global Fragment-based Drug Discovery Market Size Growth Rate by Type (2013-2018)
2.4 Fragment-based Drug Discovery Segment by Application
  2.4.1 Biopharmaceutical Companies
  2.4.2 CROs
  2.4.3 Academic and Research Institutions
2.5 Fragment-based Drug Discovery Market Size by Application
  2.5.1 Global Fragment-based Drug Discovery Market Size Market Share by Application (2013-2018)
  2.5.2 Global Fragment-based Drug Discovery Market Size Growth Rate by Application (2013-2018)

3 GLOBAL FRAGMENT-BASED DRUG DISCOVERY BY PLAYERS

3.1 Global Fragment-based Drug Discovery Market Size Market Share by Players
  3.1.1 Global Fragment-based Drug Discovery Market Size by Players (2016-2018)
  3.1.2 Global Fragment-based Drug Discovery Market Size Market Share by Players (2016-2018)
3.2 Global Fragment-based Drug Discovery Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 FRAGMENT-BASED DRUG DISCOVERY BY REGIONS

4.1 Fragment-based Drug Discovery Market Size by Regions
4.2 Americas Fragment-based Drug Discovery Market Size Growth
4.3 APAC Fragment-based Drug Discovery Market Size Growth
4.4 Europe Fragment-based Drug Discovery Market Size Growth
4.5 Middle East & Africa Fragment-based Drug Discovery Market Size Growth

5 AMERICAS

5.1 Americas Fragment-based Drug Discovery Market Size by Countries
5.2 Americas Fragment-based Drug Discovery Market Size by Type
5.3 Americas Fragment-based Drug Discovery Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Fragment-based Drug Discovery Market Size by Countries
6.2 APAC Fragment-based Drug Discovery Market Size by Type
6.3 APAC Fragment-based Drug Discovery Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Fragment-based Drug Discovery by Countries
7.2 Europe Fragment-based Drug Discovery Market Size by Type
7.3 Europe Fragment-based Drug Discovery Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Fragment-based Drug Discovery by Countries
8.2 Middle East & Africa Fragment-based Drug Discovery Market Size by Type
8.3 Middle East & Africa Fragment-based Drug Discovery Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL FRAGMENT-BASED DRUG DISCOVERY MARKET FORECAST

10.1 Global Fragment-based Drug Discovery Market Size Forecast (2018-2023)
10.2 Global Fragment-based Drug Discovery Forecast by Regions
  10.2.1 Global Fragment-based Drug Discovery Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Fragment-based Drug Discovery Forecast by Type
10.8 Global Fragment-based Drug Discovery Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Astex Pharmaceuticals
  11.1.1 Company Details
  11.1.2 Fragment-based Drug Discovery Product Offered
  11.1.3 Astex Pharmaceuticals Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Astex Pharmaceuticals News
11.2 Alveus Pharmaceuticals
  11.2.1 Company Details
  11.2.2 Fragment-based Drug Discovery Product Offered
  11.2.3 Alveus Pharmaceuticals Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Alveus Pharmaceuticals News
11.3 Beactica
  11.3.1 Company Details
  11.3.2 Fragment-based Drug Discovery Product Offered
  11.3.3 Beactica Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Beactica News
11.4 Charles River Laboratories
  11.4.1 Company Details
  11.4.2 Fragment-based Drug Discovery Product Offered
  11.4.3 Charles River Laboratories Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Charles River Laboratories News
11.5 Crown Bioscience
  11.5.1 Company Details
  11.5.2 Fragment-based Drug Discovery Product Offered
  11.5.3 Crown Bioscience Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Crown Bioscience News
11.6 Emerald BioStructures
  11.6.1 Company Details
  11.6.2 Fragment-based Drug Discovery Product Offered
  11.6.3 Emerald BioStructures Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Emerald BioStructures News
11.7 Evotec
  11.7.1 Company Details
  11.7.2 Fragment-based Drug Discovery Product Offered
  11.7.3 Evotec Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Evotec News
11.8 Kinetic Discovery
  11.8.1 Company Details
  11.8.2 Fragment-based Drug Discovery Product Offered
  11.8.3 Kinetic Discovery Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 Kinetic Discovery News
11.9 Proteros Fragments
  11.9.1 Company Details
  11.9.2 Fragment-based Drug Discovery Product Offered
  11.9.3 Proteros Fragments Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2016-2018)
  11.9.4 Main Business Overview
  11.9.5 Proteros Fragments News
11.10 Sprint Bioscience
  11.10.1 Company Details
  11.10.2 Fragment-based Drug Discovery Product Offered
  11.10.3 Sprint Bioscience Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2016-2018)
  11.10.4 Main Business Overview
  11.10.5 Sprint Bioscience News
11.11 Structure Based Design
11.12 Sygnature Discovery

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Fragment-based Drug Discovery
Figure Fragment-based Drug Discovery Report Years Considered
Figure Market Research Methodology
Figure Global Fragment-based Drug Discovery Market Size Growth Rate 2013-2023 ($ Millions)
Table Fragment-based Drug Discovery Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Fragment Screening
Table Major Players of Fragment Optimization
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Fragment-based Drug Discovery Market Size Market Share by Type (2013-2018)
Figure Global Fragment-based Drug Discovery Market Size Market Share by Type (2013-2018)
Figure Global Fragment Screening Market Size Growth Rate
Figure Global Fragment Optimization Market Size Growth Rate
Figure Fragment-based Drug Discovery Consumed in Biopharmaceutical Companies
Figure Global Fragment-based Drug Discovery Market: Biopharmaceutical Companies (2013-2018) ($ Millions)
Figure Global Biopharmaceutical Companies YoY Growth ($ Millions)
Figure Fragment-based Drug Discovery Consumed in CROs
Figure Global Fragment-based Drug Discovery Market: CROs (2013-2018) ($ Millions)
Figure Global CROs YoY Growth ($ Millions)
Figure Fragment-based Drug Discovery Consumed in Academic and Research Institutions
Figure Global Fragment-based Drug Discovery Market: Academic and Research Institutions (2013-2018) ($ Millions)
Figure Global Academic and Research Institutions YoY Growth ($ Millions)
Table Global Fragment-based Drug Discovery Market Size by Application (2013-2018) ($ Millions)
Table Global Fragment-based Drug Discovery Market Size Market Share by Application (2013-2018)
Figure Global Fragment-based Drug Discovery Market Size Market Share by Application (2013-2018)
Figure Global Fragment-based Drug Discovery Market Size in Biopharmaceutical Companies Growth Rate
Figure Global Fragment-based Drug Discovery Market Size in CROs Growth Rate
Figure Global Fragment-based Drug Discovery Market Size in Academic and Research Institutions Growth Rate
Table Global Fragment-based Drug Discovery Revenue by Players (2016-2018) ($ Millions)
Table Global Fragment-based Drug Discovery Revenue Market Share by Players (2016-2018)
Figure Global Fragment-based Drug Discovery Revenue Market Share by Players in 2017
Table Global Fragment-based Drug Discovery Key Players Head office and Products Offered
Table Fragment-based Drug Discovery Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Fragment-based Drug Discovery Market Size by Regions 2013-2018 ($ Millions)
Table Global Fragment-based Drug Discovery Market Size Market Share by Regions 2013-2018
Figure Global Fragment-based Drug Discovery Market Size Market Share by Regions 2013-2018
Figure Americas Fragment-based Drug Discovery Market Size 2013-2018 ($ Millions)
Figure APAC Fragment-based Drug Discovery Market Size 2013-2018 ($ Millions)
Figure Europe Fragment-based Drug Discovery Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Fragment-based Drug Discovery Market Size 2013-2018 ($ Millions)
Table Americas Fragment-based Drug Discovery Market Size by Countries (2013-2018) ($ Millions)
Table Americas Fragment-based Drug Discovery Market Size Market Share by Countries (2013-2018)
Figure Americas Fragment-based Drug Discovery Market Size Market Share by Countries in 2017
Table Americas Fragment-based Drug Discovery Market Size by Type (2013-2018) ($ Millions)
Table Americas Fragment-based Drug Discovery Market Size Market Share by Type (2013-2018)
Figure Americas Fragment-based Drug Discovery Market Size Market Share by Type in 2017
Table Americas Fragment-based Drug Discovery Market Size by Application (2013-2018) ($ Millions)
Table Americas Fragment-based Drug Discovery Market Size Market Share by Application (2013-2018)
Figure Americas Fragment-based Drug Discovery Market Size Market Share by Application in 2017
Figure United States Fragment-based Drug Discovery Market Size Growth 2013-2018 ($ Millions)
Figure Canada Fragment-based Drug Discovery Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Fragment-based Drug Discovery Market Size Growth 2013-2018 ($ Millions)
Table APAC Fragment-based Drug Discovery Market Size by Countries (2013-2018) ($ Millions)
Table APAC Fragment-based Drug Discovery Market Size Market Share by Countries (2013-2018)
Figure APAC Fragment-based Drug Discovery Market Size Market Share by Countries in 2017
Table APAC Fragment-based Drug Discovery Market Size by Type (2013-2018) ($ Millions)
Table APAC Fragment-based Drug Discovery Market Size Market Share by Type (2013-2018)
Figure APAC Fragment-based Drug Discovery Market Size Market Share by Type in 2017
Table APAC Fragment-based Drug Discovery Market Size by Application (2013-2018) ($ Millions)
Table APAC Fragment-based Drug Discovery Market Size Market Share by Application (2013-2018)
Figure APAC Fragment-based Drug Discovery Market Size Market Share by Application in 2017
Figure China Fragment-based Drug Discovery Market Size Growth 2013-2018 ($ Millions)
Figure Japan Fragment-based Drug Discovery Market Size Growth 2013-2018 ($ Millions)
Figure Korea Fragment-based Drug Discovery Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Fragment-based Drug Discovery Market Size Growth 2013-2018 ($ Millions)
Figure India Fragment-based Drug Discovery Market Size Growth 2013-2018 ($ Millions)
Figure Australia Fragment-based Drug Discovery Market Size Growth 2013-2018 ($ Millions)
Table Europe Fragment-based Drug Discovery Market Size by Countries (2013-2018) ($ Millions)
Table Europe Fragment-based Drug Discovery Market Size Market Share by Countries (2013-2018)
Figure Europe Fragment-based Drug Discovery Market Size Market Share by Countries in 2017
Table Europe Fragment-based Drug Discovery Market Size by Type (2013-2018) ($ Millions)
Table Europe Fragment-based Drug Discovery Market Size Market Share by Type (2013-2018)
Figure Europe Fragment-based Drug Discovery Market Size Market Share by Type in 2017
Table Europe Fragment-based Drug Discovery Market Size by Application (2013-2018) ($ Millions)
Table Europe Fragment-based Drug Discovery Market Size Market Share by Application (2013-2018)
Figure Europe Fragment-based Drug Discovery Market Size Market Share by Application in 2017
Figure Germany Fragment-based Drug Discovery Market Size Growth 2013-2018 ($ Millions)
Figure France Fragment-based Drug Discovery Market Size Growth 2013-2018 ($ Millions)
Figure UK Fragment-based Drug Discovery Market Size Growth 2013-2018 ($ Millions)
Figure Italy Fragment-based Drug Discovery Market Size Growth 2013-2018 ($ Millions)
Figure Russia Fragment-based Drug Discovery Market Size Growth 2013-2018 ($ Millions)
Figure Spain Fragment-based Drug Discovery Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Fragment-based Drug Discovery Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Fragment-based Drug Discovery Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Fragment-based Drug Discovery Market Size Market Share by Countries in 2017
Table Middle East & Africa Fragment-based Drug Discovery Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Fragment-based Drug Discovery Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Fragment-based Drug Discovery Market Size Market Share by Type in 2017
Table Middle East & Africa Fragment-based Drug Discovery Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Fragment-based Drug Discovery Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Fragment-based Drug Discovery Market Size Market Share by Application in 2017
Figure Egypt Fragment-based Drug Discovery Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Fragment-based Drug Discovery Market Size Growth 2013-2018 ($ Millions)
Figure Israel Fragment-based Drug Discovery Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Fragment-based Drug Discovery Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Fragment-based Drug Discovery Market Size Growth 2013-2018 ($ Millions)
Figure Global Fragment-based Drug Discovery arket Size Forecast (2018-2023) ($ Millions)
Table Global Fragment-based Drug Discovery Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Fragment-based Drug Discovery Market Size Market Share Forecast by Regions
Figure Americas Fragment-based Drug Discovery Market Size 2018-2023 ($ Millions)
Figure APAC Fragment-based Drug Discovery Market Size 2018-2023 ($ Millions)
Figure Europe Fragment-based Drug Discovery Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Fragment-based Drug Discovery Market Size 2018-2023 ($ Millions)
Figure United States Fragment-based Drug Discovery Market Size 2018-2023 ($ Millions)
Figure Canada Fragment-based Drug Discovery Market Size 2018-2023 ($ Millions)
Figure Mexico Fragment-based Drug Discovery Market Size 2018-2023 ($ Millions)
Figure Brazil Fragment-based Drug Discovery Market Size 2018-2023 ($ Millions)
Figure China Fragment-based Drug Discovery Market Size 2018-2023 ($ Millions)
Figure Japan Fragment-based Drug Discovery Market Size 2018-2023 ($ Millions)
Figure Korea Fragment-based Drug Discovery Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Fragment-based Drug Discovery Market Size 2018-2023 ($ Millions)
Figure India Fragment-based Drug Discovery Market Size 2018-2023 ($ Millions)
Figure Australia Fragment-based Drug Discovery Market Size 2018-2023 ($ Millions)
Figure Germany Fragment-based Drug Discovery Market Size 2018-2023 ($ Millions)
Figure France Fragment-based Drug Discovery Market Size 2018-2023 ($ Millions)
Figure UK Fragment-based Drug Discovery Market Size 2018-2023 ($ Millions)
Figure Italy Fragment-based Drug Discovery Market Size 2018-2023 ($ Millions)
Figure Russia Fragment-based Drug Discovery Market Size 2018-2023 ($ Millions)
Figure Spain Fragment-based Drug Discovery Market Size 2018-2023 ($ Millions)
Figure Egypt Fragment-based Drug Discovery Market Size 2018-2023 ($ Millions)
Figure South Africa Fragment-based Drug Discovery Market Size 2018-2023 ($ Millions)
Figure Israel Fragment-based Drug Discovery Market Size 2018-2023 ($ Millions)
Figure Turkey Fragment-based Drug Discovery Market Size 2018-2023 ($ Millions)
Figure GCC Countries Fragment-based Drug Discovery Market Size 2018-2023 ($ Millions)
Table Global Fragment-based Drug Discovery Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Fragment-based Drug Discovery Market Size Market Share Forecast by Type (2018-2023)
Table Global Fragment-based Drug Discovery Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Fragment-based Drug Discovery Market Size Market Share Forecast by Application (2018-2023)
Table Astex Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Astex Pharmaceuticals Fragment-based Drug Discovery Revenue and Gross Margin (2016-2018)
Figure Astex Pharmaceuticals Fragment-based Drug Discovery Market Share (2016-2018)
Table Alveus Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Alveus Pharmaceuticals Fragment-based Drug Discovery Revenue and Gross Margin (2016-2018)
Figure Alveus Pharmaceuticals Fragment-based Drug Discovery Market Share (2016-2018)
Table Beactica Basic Information, Head Office, Major Market Areas and Its Competitors
Table Beactica Fragment-based Drug Discovery Revenue and Gross Margin (2016-2018)
Figure Beactica Fragment-based Drug Discovery Market Share (2016-2018)
Table Charles River Laboratories Basic Information, Head Office, Major Market Areas and Its Competitors
Table Charles River Laboratories Fragment-based Drug Discovery Revenue and Gross Margin (2016-2018)
Figure Charles River Laboratories Fragment-based Drug Discovery Market Share (2016-2018)
Table Crown Bioscience Basic Information, Head Office, Major Market Areas and Its Competitors
Table Crown Bioscience Fragment-based Drug Discovery Revenue and Gross Margin (2016-2018)
Figure Crown Bioscience Fragment-based Drug Discovery Market Share (2016-2018)
Table Emerald BioStructures Basic Information, Head Office, Major Market Areas and Its Competitors
Table Emerald BioStructures Fragment-based Drug Discovery Revenue and Gross Margin (2016-2018)
Figure Emerald BioStructures Fragment-based Drug Discovery Market Share (2016-2018)
Table Evotec Basic Information, Head Office, Major Market Areas and Its Competitors
Table Evotec Fragment-based Drug Discovery Revenue and Gross Margin (2016-2018)
Figure Evotec Fragment-based Drug Discovery Market Share (2016-2018)
Table Kinetic Discovery Basic Information, Head Office, Major Market Areas and Its Competitors
Table Kinetic Discovery Fragment-based Drug Discovery Revenue and Gross Margin (2016-2018)
Figure Kinetic Discovery Fragment-based Drug Discovery Market Share (2016-2018)
Table Proteros Fragments Basic Information, Head Office, Major Market Areas and Its Competitors
Table Proteros Fragments Fragment-based Drug Discovery Revenue and Gross Margin (2016-2018)
Figure Proteros Fragments Fragment-based Drug Discovery Market Share (2016-2018)
Table Sprint Bioscience Basic Information, Head Office, Major Market Areas and Its Competitors
Table Sprint Bioscience Fragment-based Drug Discovery Revenue and Gross Margin (2016-2018)
Figure Sprint Bioscience Fragment-based Drug Discovery Market Share (2016-2018)
Table Structure Based Design Basic Information, Head Office, Major Market Areas and Its Competitors
Table Sygnature Discovery Basic Information, Head Office, Major Market Areas and Its Competitors